DNAVax, created in 1997 (United States), from 3 sister brands and 2214 competing brands. DNAVax is owned by Inovio Pharma, listed on the stock exchange of New York DNAVax is part of the Biotechnology activity sector.

DNAVax is a brand of Inovio Pharma (INO) Share price

International deposit : 1997 Business sector Biotechnology

Share price and profitability of the share Inovio Pharma (DNAVax)

Buy Inovio Pharma share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 10.02

Portfolio valuation
Inovio Pharma (DNAVax) over 5 years* USD 2.17

Stock market history Inovio Pharma (DNAVax)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Inovio Pharma

See more brands of Inovio Pharma

Rival brands
DNAVax

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS